Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


25.02.2019

1 Am J Ophthalmol
1 Am J Surg
1 Biochem Biophys Res Commun
1 Br J Dermatol
2 Cancer Res
2 Clin Cancer Res
1 J Am Acad Dermatol
1 J Cell Physiol
1 J Invest Dermatol
3 Melanoma Res
2 Oncogene
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Ophthalmol

  1. JOUHI S, Jager MJ, de Geus SJR, Desjardins L, et al
    THE SMALL FATAL CHOROIDAL MELANOMA STUDY A Survey by the European Ophthalmic Oncology Group.
    Am J Ophthalmol. 2019 Feb 14. pii: S0002-9394(19)30062.
    PubMed     Text format     Abstract available


    Am J Surg


  2. Melanoma: Improvement in guideline based care using a quality monitoring program. Comparison of melanoma care outcomes in a community-based teaching hospital.
    Am J Surg. 2019;217:532-533.
    PubMed     Text format    


    Biochem Biophys Res Commun

  3. JIAO JX, Jiao LJ, Yang S, Zhao YJ, et al
    Knockdown of aristaless-like homeobox1 inhibits epithelial-mesenchymal transition through Wnt/beta-catenin signaling pathway in melanoma cells.
    Biochem Biophys Res Commun. 2019 Feb 14. pii: S0006-291X(19)30237.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. RESSLER J, Silmbrod R, Stepan A, Tuchmann F, et al
    T-VEC in advanced Melanoma - Complete response in a heart and kidney transplant patient: A case report.
    Br J Dermatol. 2019 Feb 18. doi: 10.1111/bjd.17783.
    PubMed     Text format     Abstract available


    Cancer Res

  5. TURANI Z, Fatemizadeh E, Blumetti T, Daveluy S, et al
    Optical Radiomic Signatures Derived from Optical Coherence Tomography Images to Improve Identification of Melanoma.
    Cancer Res. 2019 Feb 18. pii: 0008-5472.CAN-18-2791.
    PubMed     Text format     Abstract available

  6. POZNIAK J, Nsengimana J, Laye JP, O'Shea SJ, et al
    Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma.
    Cancer Res. 2019 Feb 17. pii: 0008-5472.CAN-18-2864.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  7. ZHOU R, Shi C, Tao W, Li J, et al
    Analysis of mucosal melanoma whole-genome landscapes reveals clinically relevant genomic aberrations.
    Clin Cancer Res. 2019 Feb 19. pii: 1078-0432.CCR-18-3442.
    PubMed     Text format     Abstract available

  8. EDWARDS JJ, Tasker A, Silva I, Quek C, et al
    Prevalence and cellular distribution of novel immune checkpoint targets across longitudinal specimens in treatment-naive melanoma: implications for clinical trials.
    Clin Cancer Res. 2019 Feb 18. pii: 1078-0432.CCR-18-4011.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  9. GOLDSMITH SM
    Clinicopathologic, misdiagnosis and survival differences between clinically amelanotic melanomas and pigmented melanomas.
    J Am Acad Dermatol. 2019 Feb 15. pii: S0190-9622(19)30285.
    PubMed     Text format    


    J Cell Physiol

  10. LUAN W, Zhang X, Ruan H, Wang J, et al
    Long noncoding RNA OIP5-AS1 acts as a competing endogenous RNA to promote glutamine catabolism and malignant melanoma growth by sponging miR-217.
    J Cell Physiol. 2019 Feb 18. doi: 10.1002/jcp.28335.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  11. DAVIDSON G, Coassolo S, Kieny A, Ennen M, et al
    Dynamic evolution of clonal composition and neoantigen landscape in recurrent metastatic melanoma with a rare combination of driver mutations.
    J Invest Dermatol. 2019 Feb 15. pii: S0022-202X(19)30108.
    PubMed     Text format     Abstract available


    Melanoma Res

  12. DRYSDALE E, Peng Y, Nguyen P, Baetz T, et al
    A population-based study of the treatment effect of first-line ipilimumab for metastatic or unresectable melanoma.
    Melanoma Res. 2019 Feb 14. doi: 10.1097/CMR.0000000000000582.
    PubMed     Text format     Abstract available

  13. BORGOGNONI L, Bellucci F, Urso C, Manneschi G, et al
    Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: clinical usefulness in patients who do not undergo complete lymph node dissection.
    Melanoma Res. 2018 Jul 17. doi: 10.1097/CMR.0000000000000481.
    PubMed     Text format     Abstract available

  14. YANG Y, Zhe H, Massoumi R, Ke H, et al
    Decreased expression of nemo-like kinase in melanoma is correlated with increased vascularity and metastasis.
    Melanoma Res. 2019 Jan 10. doi: 10.1097/CMR.0000000000000576.
    PubMed     Text format     Abstract available


    Oncogene

  15. MORRIS SM, Mhyre AJ, Carmack SS, Myers CH, et al
    A modified gene trap approach for improved high-throughput cancer drug discovery.
    Oncogene. 2018;37:4226-4238.
    PubMed     Text format     Abstract available

  16. KLOSE R, Adam MG, Weis EM, Moll I, et al
    Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis.
    Oncogene. 2018;37:4260-4272.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  17. LI C, Nguyen V, Clark KN, Zahed T, et al
    Down-regulation of FZD3 receptor suppresses growth and metastasis of human melanoma independently of canonical WNT signaling.
    Proc Natl Acad Sci U S A. 2019 Feb 21. pii: 1813802116.
    PubMed     Text format     Abstract available

  18. GUPTA R, Bugide S, Wang B, Green MR, et al
    Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating MAP kinase pathway.
    Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1821889116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: